Chief Executive Officer, Claritas GenomicsBiography
Dr. Milos recently joined Claritas Genomics, a newly formed company focused on pediatric molecular diagnostics emerging from Boston Children's Hospital in partnership with Life Technologies. Claritas Genomics combines the power of next-generation DNA sequencing technology with the clinical expertise of the world's best pediatric specialists to inform and improve patient care. Patrice most recently served as the Boston Site Head for Pfizer's Centers of Therapeutic Innovation and Precision Medicine Lead. The CTI model represented a new and exciting approach to drug discovery through establishment of academic medical center partnerships, including Beth Israel, Boston Children's Hospital, Tufts Medical Center, Boston University School of Medicine and Partners Healthcare, along with Pfizer to establish proof of mechanism for novel targets and pathways aiming to treat human disease. Dr. Milos previously served as the Senior Vice President and Chief Scientific Officer for Helicos BioSciences Corporation, Cambridge, MA joining in June 2007. Her expertise and extensive knowledge in the life sciences helped advance the company's efforts to develop and apply innovative and breakthrough single molecule DNA and RNA sequencing technology with recent focus on molecular diagnostics. Accomplishments included the development of the world's first and only method for direct capture and sequencing of BRCA1/2, the only method for direct sequencing of RNA as well as the establishment of collaborations with world class institutions including the Broad Institute, Harvard Medical School, Massachusetts General Hospital and the Children's Oncology Group. Patrice's previously served as Executive Director for Pfizer Global Research and Development, Groton, CT. Patrice was responsible for leadership, strategy alignment and execution of the scientific disciplines of pharmacogenomics, proteomics, metabonomics and RNA profiling applied across the Pfizer portfolio from early discovery into the marketplace. Initially joining Pfizer in 1993, Dr. Milos held numerous research positions of increasing responsibility focusing on Cardiovascular and Metabolic Disease, Pharmacogenomics, DNA Sequencing, Biomarkers and Molecular Sciences. Dr. Milos serves on the Boston Children's Hospital Technology Advisory Board, is an active NIH grant reviewer and has served on the National Advisory Council for Human Genome Research. Patrice was also pivotal in the establishment and oversight of key Pfizer strategic investments in the genomics area, most notably, the Genetic Association Information Network in partnership with NIH. She also sits on several journal editorial boards and has published and presented extensively in genomic sciences. Dr. Milos conducted post-doctoral fellowships at Brown University and Harvard University. She earned her MS and PhD degrees at Rensselaer Polytechnic Institute in Troy, NY.